Gregory K. Chow, Executive VP & CFO at Aptose Biosciences Inc. (APTO), sold 253,336 shares at $6.05 ($1.5M) on 2020-07-10, disclosed to the SEC on 2020-07-10.
Open-market sale of $1.5M APTO by Executive VP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.05 | 126,668 | $766K | 50.0% |
| 2 | $6.05 | 126,668 | $766K | 50.0% |
| Total | $6.05 avg | 253,336 | $1.5M | 100% |
| Filing → |
| APTO | BUY | 2019-03-14 | $26K | — | Filing → |